Difference between revisions of "Team:Tianjin/Design"

Line 238: Line 238:
 
               <hr>
 
               <hr>
 
       <p>After we found there might be revolutionary usage about the mating type switch (<b>MTS</b>) of yeasts in our heavy metal deposition system, In laboratory, the species of budding yeast we usually used are <i>BY4741</i> and <i>BY4742</i>, whose <i>HO</i> gene are knocked out. Therefore, we intended to use two groups of <i>MATa</i> yeasts to realize the mating switcher. </p>
 
       <p>After we found there might be revolutionary usage about the mating type switch (<b>MTS</b>) of yeasts in our heavy metal deposition system, In laboratory, the species of budding yeast we usually used are <i>BY4741</i> and <i>BY4742</i>, whose <i>HO</i> gene are knocked out. Therefore, we intended to use two groups of <i>MATa</i> yeasts to realize the mating switcher. </p>
<p>One of these groups was required to achieve <b>MTS</b>. We decided to achieve <b>MTS</b> by introducing the <i>HO</i> gene into this group of yeasts— Saccharomyces cerevisiae (<i>BY4741</i>, in our lab, whose chromosome Ⅹhas been switched by synthetic chromosome Ⅹ. And it has been renamed as SynⅩsimilarly hereinafter). To make the <b>MTS</b> controllable, it is necessary for us to adopt inducible promoters to initiate the expression of <i>HO</i> gene or create a pathway functioning as single gene regulator. Eventually, we landed on the <i>Gal1</i> promoter first, for its convenience and efficiency. As we read in R. Scott McIsaac’s work, their rapid, tunable, single-gene specificity control system of single gene in yeasts has given us much impression. Therefore, we decided to use this system as one of our pathway designs for the expression of <i>HO</i> gene. </p>
+
<p>One of these groups was required to achieve <b>MTS</b>. We decided to achieve <b>MTS</b> by introducing the <i>HO</i> gene into this group of yeasts— Saccharomyces cerevisiae (<i>BY4741</i>, in our lab, whose chromosome Ⅹhas been switched by synthetic chromosome Ⅹ. And it has been renamed as <i>SynⅩ</i> similarly hereinafter). To make the <b>MTS</b> controllable, it is necessary for us to adopt inducible promoters to initiate the expression of <i>HO</i> gene or create a pathway functioning as single gene regulator. Eventually, we landed on the <i>Gal1</i> promoter first, for its convenience and efficiency. As we read in R. Scott McIsaac’s work, their rapid, tunable, single-gene specificity control system of single gene in yeasts has given us much impression. Therefore, we decided to use this system as one of our pathway designs for the expression of <i>HO</i> gene. </p>
 
                     <h4>GETTING THE CHASSIS </h4>
 
                     <h4>GETTING THE CHASSIS </h4>
 
                     <hr>  
 
                     <hr>  
 
             <p>Aiming to achieve <b>MTS</b> for environmental use, it is essential to make sure that when the<i>MATa</i> locus has DSB(double strands break) cleaved by <i>HO</i>, our type-a (<i>MATa</i>) yeast can only become type-α (<i>MATα</i>). Therefore, we used a Ura-tag to replace the HMR(a) domain in chromosome Ⅲ. In this way, the HMR will no longer be the donor for the homologous recombination in the repairing process for <i>MATa</i> cleavage. </p>
 
             <p>Aiming to achieve <b>MTS</b> for environmental use, it is essential to make sure that when the<i>MATa</i> locus has DSB(double strands break) cleaved by <i>HO</i>, our type-a (<i>MATa</i>) yeast can only become type-α (<i>MATα</i>). Therefore, we used a Ura-tag to replace the HMR(a) domain in chromosome Ⅲ. In this way, the HMR will no longer be the donor for the homologous recombination in the repairing process for <i>MATa</i> cleavage. </p>
<p>Since the change of mating type may appear successively, there is a great possibility that the same type haploid mate with each other. To avoid the existence of meaningless mating, we built a vector to express <i>MATα</i> genes to produce a1-α2 stable corepressor so that the haploid will regard itself as a diploid and prevent mating unless the <i>MATa</i> locus changes to the other one. After selection, by homologous recombination, we deleted the Ura-tag for further usage. We selected the target colonies(SynⅩdUra)  via 5Foa plates.  </p>
+
<p>Since the change of mating type may appear successively, there is a great possibility that the same type haploid mate with each other. To avoid the existence of meaningless mating, we built a vector to express <i>MATα</i> genes to produce a1-α2 stable corepressor so that the haploid will regard itself as a diploid and prevent mating unless the <i>MATa</i> locus changes to the other one. After selection, by homologous recombination, we deleted the Ura-tag for further usage. We selected the target colonies(<i>SynⅩdUra</i>)  via 5Foa plates.  </p>
 
  <div class="zxx_zoom_demo_long" align="center">
 
  <div class="zxx_zoom_demo_long" align="center">
 
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
 
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
Line 259: Line 259:
 
         <h5> 1) <i>Gal1</i> System</h5>
 
         <h5> 1) <i>Gal1</i> System</h5>
 
            
 
            
         <p>In this pathway, we chose <i>Gal1</i> as our promoter for the expression of <i>HO</i> gene, CYC1 as the terminator, and PRS416(with Ura-tag) as our vector. As for segments ligation, we design the cutting sites for the Bsa1 enzyme in each part, hoping to achieve seamless ligation of these three parts. </p>
+
         <p>In this pathway, we chose <i>Gal1</i> as our promoter for the expression of <i>HO</i> gene, <i>CYC1</i> as the terminator, and PRS416(with Ura-tag) as our vector. As for segments ligation, we design the cutting sites for the Bsa1 enzyme in each part, hoping to achieve seamless ligation of these three parts. </p>
           <p>We adopted the PCR method to amplify the <i>Gal1</i>-part and CYC1-part from a <i>Gal1</i>-Vika plasmid we had used in our former lab work. We designed specific primers for this procedure. After PCR, the <i>Gal1</i> has the cutting sites for SalⅠand BsaⅠon both ends, and CYC1 has that for BsaⅠand BamhⅠon both ends. Meanwhile, the <i>HO</i> gene was obtained by gene synthesis, flanked by specific hangtags for BsaⅠto be cohesive with <i>Gal1</i> upstream and CYC1 downstream. Thus, we have built our composite part (GHC).</p>
+
           <p>We adopted the PCR method to amplify the <i>Gal1</i>-part and <i>CYC1</i>-part from a <i>Gal1-Vika</i> plasmid we had used in our former lab work. We designed specific primers for this procedure. After PCR, the <i>Gal1</i> has the cutting sites for SalⅠand BsaⅠon both ends, and <i>CYC1</i> has that for BsaⅠand BamhⅠon both ends. Meanwhile, the <i>HO</i> gene was obtained by gene synthesis, flanked by specific hangtags for BsaⅠto be cohesive with <i>Gal1</i> upstream and <i>CYC1</i> downstream. Thus, we have built our composite part (<i>GHC</i>).</p>
       <p>After the ligation, we transformed the E.coli for the augment of the PRS416 plasmid with GHC. (GHC-416) And eventually, we transformed our SynⅩ-dUra for the GHC-416 to get our target yeasts——SynⅩ-dUra-416. </p>
+
       <p>After the ligation, we transformed the E.coli for the augment of the PRS416 plasmid with <i>GHC</i>. (<i>GHC-416</i>) And eventually, we transformed our <i>SynⅩ-dUra</i> for the <i>GHC-416</i> to get our target yeasts——<i>SynⅩ-dUra-416</i>. </p>
  
 
         <h5> 2) <i>Modified. Gal1</i> system </h5>
 
         <h5> 2) <i>Modified. Gal1</i> system </h5>
 
              
 
              
         <p>In this pathway, we introduced one kind of artificial transcription factor (ATF)—Z4EV into the regulation of <i>HO</i> gene expression. With Z4EV working with our Modified. <i>Gal1</i> promoter, we hoped to reach the on off-target dynamic control of <i>HO</i> gene expression.  
+
         <p>In this pathway, we introduced one kind of artificial transcription factor (ATF)—<i>Z4EV</i> into the regulation of <i>HO</i> gene expression. With <i>Z4EV</i> working with our <i>Modified. Gal1</i> promoter, we hoped to reach the on off-target dynamic control of <i>HO</i> gene expression.  
Our designing for getting the Modified. Gal1-HO-CYC1 parts (<b>MGHC</b>) is quite the same as that for GHC mentioned above, only that we acquired our Modified. <i>Gal1</i> part from the gene synthesis. </p>
+
Our designing for getting the <i>Modified. Gal1-HO-CYC1</i> parts (<b>MGHC</b>) is quite the same as that for <i>GHC</i> mentioned above, only that we acquired our Modified. <i>Gal1</i> part from the gene synthesis. </p>
 
  <div class="zxx_zoom_demo_long" align="center">
 
  <div class="zxx_zoom_demo_long" align="center">
 
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
 
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
Line 280: Line 280:
  
  
         <p>As for the expression of Z4EV gene, we intended to induce it into the SynX chromosome in SynⅩ-dUra by homologous recombination. With overlap PCR strategy, we put a homologous domain <i>CanA</i> (originally from Can gene in chromosome X) in the upstream of the promoter of Z4EV. Thus, we got our <i>CanA-TEF-Z4EV</i> part. Then we planned to use Tdh2t as terminator attached with Leu-CanB (another part of Can gene). </p>
+
         <p>As for the expression of <i>Z4EV</i> gene, we intended to induce it into the <i>SynX</i> chromosome in <i>SynⅩ-dUra</i> by homologous recombination. With overlap PCR strategy, we put a homologous domain <i>CanA</i> (originally from Can gene in <i>chromosome X</i>) in the upstream of the promoter of <i>Z4EV</i>. Thus, we got our <i>CanA-TEF-Z4EV</i> part. Then we planned to use Tdh2t as terminator attached with Leu-CanB (another part of Can gene). </p>
  
         <p>Next, for double using the Leu-tag, we introduce Vika/vox system. We intended to attach the Vika operator (Tdh3p-Vika-Tdh2t, TVT) following the Z4EV gene. We had two groups of yeasts, as mentioned above, one of them aimed to accomplish MTS and becoming <i>MATα</i>, the other with functional genes remained as <i>MATa</i>. According to our design, the former will express Vika recombinase, and the other contains functional genes whose expressions are controlled by vox-Terminator-vox structure. Thus, the function gene’s expression will be initiated during the cell fusion in yeast mating process.  </p>
+
         <p>Next, for double using the Leu-tag, we introduce <i>Vika/vox</i> system. We intended to attach the <i>Vika</i> operator (<i>Tdh3p-Vika-Tdh2t</i>, TVT) following the <i>Z4EV</i> gene. We had two groups of yeasts, as mentioned above, one of them aimed to accomplish <b>MTS</b> and becoming <i>MATα</i>, the other with functional genes remained as <i>MATa</i>. According to our design, the former will express <i>Vika</i> recombinase, and the other contains functional genes whose expressions are controlled by vox-Terminator-vox structure. Thus, the function gene’s expression will be initiated during the cell fusion in yeast mating process.  </p>
 
  <div class="zxx_zoom_mid" align="center">
 
  <div class="zxx_zoom_mid" align="center">
 
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
 
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
Line 288: Line 288:
 
                         <a href="#pic_hao">
 
                         <a href="#pic_hao">
 
                           <img src=" https://static.igem.org/mediawiki/2017/a/a6/Tianjin-ho-design-fig3.jpeg"></a>
 
                           <img src=" https://static.igem.org/mediawiki/2017/a/a6/Tianjin-ho-design-fig3.jpeg"></a>
<p style="font-size:15px;text-align:center"><br/>Fig. 1-3. Z4EV and Vika. </p>
+
<p style="font-size:15px;text-align:center"><br/>Fig. 1-3. <i>Z4EV</i> and <i>Vika</i>. </p>
 
                     </div>
 
                     </div>
 
                    
 
                    
 
                     </div>
 
                     </div>
 
                    
 
                    
                   <div id="pic_hao" style="display:none;"><img src=" https://static.igem.org/mediawiki/2017/a/a6/Tianjin-ho-design-fig3.jpeg"><p style="font-size:15px;text-align:center"><br/>Fig. 1-3. Z4EV and Vika.
+
                   <div id="pic_hao" style="display:none;"><img src=" https://static.igem.org/mediawiki/2017/a/a6/Tianjin-ho-design-fig3.jpeg"><p style="font-size:15px;text-align:center"><br/>Fig. 1-3. <i>Z4EV</i> and <i>Vika</i>.
 
</p></div>  
 
</p></div>  
 
                 <h4>TEST of <b>MTS</b> </h4>
 
                 <h4>TEST of <b>MTS</b> </h4>
Line 300: Line 300:
 
<p>The whole test process can be divided into three steps. </p>
 
<p>The whole test process can be divided into three steps. </p>
 
                 <h5>Step 1:</h5>  
 
                 <h5>Step 1:</h5>  
           <p>Activate the <i>Gal1</i> promoter. After that, the expression of <i>HO</i> gene in the SynⅩ-dUra-416 can be initiated.</p>
+
           <p>Activate the <i>Gal1</i> promoter. After that, the expression of <i>HO</i> gene in the <i>SynⅩ-dUra-416</i> can be initiated.</p>
 
                 <h5>Step 2:</h5>
 
                 <h5>Step 2:</h5>
           <p> Cultivate two groups of yeasts together. (one is SynⅩ-dUra-416, the other is normal <i>BY4741</i><i>MATa</i>) If the <b>MTS </b> has been accomplished (SynⅩ-dUra-416 can become <i>MATα</i>), the two groups of haploids can mate with each other and become diploids. </p>
+
           <p> Cultivate two groups of yeasts together. (one is <i>SynⅩ-dUra-416</i>, the other is normal <i>BY4741</i><i>MATa</i>) If the <b>MTS </b> has been accomplished (<i>SynⅩ-dUra-416</i> can become <i>MATα</i>), the two groups of haploids can mate with each other and become diploids. </p>
 
                 <h5>Step 3:</h5>
 
                 <h5>Step 3:</h5>
 
           <p> Test the results of mating by PCR method. We designed the primers for both <i>MATa</i> locus and <i>MATα</i> locus. The amplification of both <i>MATa</i> locus and <i>MATα</i> locus indicates that the yeasts have turned into diploids, the <b>MTS</b> has been achieved in other words. </p>
 
           <p> Test the results of mating by PCR method. We designed the primers for both <i>MATa</i> locus and <i>MATα</i> locus. The amplification of both <i>MATa</i> locus and <i>MATα</i> locus indicates that the yeasts have turned into diploids, the <b>MTS</b> has been achieved in other words. </p>
Line 323: Line 323:
 
                   <div id="pic_four" style="display:none;"><img src="  https://static.igem.org/mediawiki/2017/6/6f/Tianjin-ho-design-fig4.jpeg"><p style="font-size:15px;text-align:center"><br/>Fig. 1-4. Mating switch of yeasts</p></div>  
 
                   <div id="pic_four" style="display:none;"><img src="  https://static.igem.org/mediawiki/2017/6/6f/Tianjin-ho-design-fig4.jpeg"><p style="font-size:15px;text-align:center"><br/>Fig. 1-4. Mating switch of yeasts</p></div>  
  
                   <h5>Artificial Transcription Factors——Z4EV</h5>
+
                   <h5>Artificial Transcription Factors——<i>Z4EV</i></h5>
               <p>Thanks to R. Scott McIsaac and Benjamin L. Oakes’s former work, we learned that Z4EV is a kind of fusion protein with three domains –a DNA binding domain (DBD), an estrogen receptor (ER) and a VP16 activation domain. In the absence of β-estradiol, the ER interacts with Hsp90 chaperone complex and keep the ATF out of the nucleus. This AFT will provide a strong transcriptional activator that is dependent on the presence of β-estradiol. By using a synthetic 4-time-repeated zinc-finger DBD array from the mouse TF Zif268, residual off-target effects have been totally avoided. </p>
+
               <p>Thanks to R. Scott McIsaac and Benjamin L. Oakes’s former work, we learned that <i>Z4EV</i> is a kind of fusion protein with three domains –a DNA binding domain (DBD), an estrogen receptor (ER) and a VP16 activation domain. In the absence of β-estradiol, the ER interacts with Hsp90 chaperone complex and keep the ATF out of the nucleus. This AFT will provide a strong transcriptional activator that is dependent on the presence of β-estradiol. By using a synthetic 4-time-repeated zinc-finger DBD array from the mouse TF Zif268, residual off-target effects have been totally avoided. </p>
                 <p>Z4EV (the Z4EV gene has been introduced into the SynX chromosome of this group of haploids) to strictly control the expression of <i>HO</i> gene. Unlike common β-estradiol-induced or galactose-induced promoters, this modified promoter is designed to be activated only when it is specifically bound with the activated Z4EV factor. </p>
+
                 <p><i>Z4EV</i> (the <i>Z4EV</i> gene has been introduced into the <i>SynX chromosome</i> of this group of haploids) to strictly control the expression of <i>HO</i> gene. Unlike common β-estradiol-induced or galactose-induced promoters, this modified promoter is designed to be activated only when it is specifically bound with the activated <i>Z4EV</i> factor. </p>
 
  <div class="zxx_zoom_demo" align="center">
 
  <div class="zxx_zoom_demo" align="center">
 
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
 
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
Line 331: Line 331:
 
                         <a href="#pic_fours">
 
                         <a href="#pic_fours">
 
                           <img src="https://static.igem.org/mediawiki/2017/0/05/Tianjindajie6666.png"></a>
 
                           <img src="https://static.igem.org/mediawiki/2017/0/05/Tianjindajie6666.png"></a>
<p style="font-size:15px;text-align:center"><br/>Fig. 1-5. Artificial Transcription Factors——Z4EV</p>
+
<p style="font-size:15px;text-align:center"><br/>Fig. 1-5. Artificial Transcription Factors——<i>Z4EV</i></p>
 
                     </div>
 
                     </div>
 
                    
 
                    
 
                     </div>
 
                     </div>
 
                    
 
                    
                   <div id="pic_fours" style="display:none;"><img src="https://static.igem.org/mediawiki/2017/0/05/Tianjindajie6666.png"><p style="font-size:15px;text-align:center"><br/>Fig. 1-5. Artificial Transcription Factors——Z4EV</p></div>  
+
                   <div id="pic_fours" style="display:none;"><img src="https://static.igem.org/mediawiki/2017/0/05/Tianjindajie6666.png"><p style="font-size:15px;text-align:center"><br/>Fig. 1-5. Artificial Transcription Factors——<i>Z4EV</i></p></div>  
  
  

Revision as of 12:48, 31 October 2017

/* OVERRIDE IGEM SETTINGS */

Design


Background

Human existence on earth is almost impossible without the heavy metals. Even though important to mankind, exposure to them during production, usage and their uncontrolled discharge into the environment has caused lots of hazards to man, other organisms and the environment itself. Heavy metals can enter human tissues and organs via inhalation, diet, and manual handling. As the process of urbanization and industrialization goes deeper and deeper, heavy metal pollution, a noticeable threaten to almost all the creatures, has become an essential problem to solve.

According to our human practice, the situation of heavy metal pollution (copper and cadmium ions) is marked on a world map, and the severity of heavy metal pollution has been increasing all over this map. Places with serious pollution include middle Asia, eastern Asia, southern Europe, and Latin America. In addition, not only fresh water source, but also soil and crops are seriously contaminated by heavy metals. On average, during three out of ten suppers we have, we absorb excess heavy metals over the standard concentration.

Considering the rigorous situation we face, our team decided to design an advanced system for typical toxic heavy metal disposal based on Saccharomyces cerevisiae.